Skip to main
CX

CX Stock Forecast & Price Target

CX Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 25%
Buy 50%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Cemex SAB de CV has demonstrated a positive trajectory in its financial health, particularly with an improvement in the free cash flow (FCF) conversion ratio, which is projected to increase from approximately 33% in 2025 compared to 28% in 2019. The company’s strategic focus on developed markets has enhanced risk-adjusted returns, while operations in Mexico, which contribute about 40% to EBITDA, have gained pricing power to offset higher energy costs. Additionally, Cemex is expected to further enhance its FCF conversion ratios and has significantly reduced its adjusted leverage from 5.1x in 2019 to a projected 2.5x by 2025, along with a substantial improvement in reported interest coverage from 3.4x to 7.7x.

Bears say

Cemex's growth potential appears limited as business confidence remains low, closely tied to ongoing pressures on gross capital formation that have persisted since late 2018. Additionally, the company's planned decline of approximately US$400 million in capital expenditures over the next few years indicates a retrenchment that may adversely affect future operational capabilities and profitability. Compounding these challenges are controversial constitutional reforms in Mexico, which could impede large capital investments and further undermine both current and future cement demand.

CX has been analyzed by 8 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 50% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cemex SAB de CV and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cemex SAB de CV (CX) Forecast

Analysts have given CX a Buy based on their latest research and market trends.

According to 8 analysts, CX has a Buy consensus rating as of Apr 22, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $11.71, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $11.71, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cemex SAB de CV (CX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.